{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:52:34Z","timestamp":1772142754522,"version":"3.50.1"},"posted":{"date-parts":[[2025,2,27]]},"group-title":"Nephrology","reference-count":44,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.medrxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,2,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Sparsentan, a dual endothelin receptor A inhibitor and angiotensin blocker, reduced proteinuria in patients with focal segmental glomerulosclerosis (FSGS) in Phase II and Phase III studies. However, the estimated glomerular filtration rate (eGFR) endpoint was not achieved, partially attributed to disease heterogeneity among participants. Sparsentan reversed the molecular fingerprint in kidneys of an adriamycin-challenged rat model of chronic kidney disease, consistent with the phenotypic data. Transcriptomic profiles from this model were used to identify differentially expressed genes, 388 of which had reversed directionality, and networks responsive to sparsentan. These included disease networks relevant to FSGS, including suppression of cytokine signaling, immune and inflammatory pathways as well as inhibition of networks downstream of endothelin and angiotensin activation. Human orthologs of genes upregulated and reversed by sparsentan in the rat model were elevated in glomerular (p&lt;0.001) and tubulointerstitial (p&lt;0.0001) profiles of participants with FSGS in the Nephrotic Syndrome Study Network (NEPTUNE) compared to healthy living donors, pointing to a likely anti- inflammatory action of sparsentan on kidneys. The gene signature in both compartments was negatively correlated with eGFR (p&lt;0.005) and positively correlated with UPCR (p&lt;0.005) and the response profile was elevated in a molecular subgroup of patients with greater disease severity. Several urine proteins were associated with the sparsentan response score highlighting opportunities for the development of non-invasive surrogates of sparsentan response to enable a precision medicine approach for treatment with dual endothelin angiotensin receptor antagonists.<\/jats:p>\n                <jats:sec>\n                  <jats:title>Translational Statement<\/jats:title>\n                  <jats:p>Cross-species mapping of sparsentan response in rat and human studies identified similar networks which were elevated in a subset of people with more severe focal segmental glomerulosclerosis (FSGS) providing the basis for implementing precision medicine in for sparsentan treatment.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.02.26.25322958","type":"posted-content","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T22:56:08Z","timestamp":1740696968000},"source":"Crossref","is-referenced-by-count":2,"title":["Framework for precision medicine in focal segmental glomerulosclerosis: Translation of sparsentan-responsive genes in a rat model to kidney disease associated proteins in biofluids"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8578-3443","authenticated-orcid":false,"given":"Sean","family":"Eddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viji","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian","family":"Fermin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Eichinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey B","family":"Hodgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura H.","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia W.","family":"Bedard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia P.","family":"Jenkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Hendry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radko","family":"Komers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jula","family":"Inrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1442-7617","authenticated-orcid":false,"given":"Matthias","family":"Kretzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Nephrotic Syndrome Study Network (NEPTUNE)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025030100250630000_2025.02.26.25322958v1.1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq665"},{"key":"2025030100250630000_2025.02.26.25322958v1.2","unstructured":"United States Renal Data System. 2022 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD."},{"key":"2025030100250630000_2025.02.26.25322958v1.3","doi-asserted-by":"crossref","unstructured":"Bensink ME , Goldschmidt D , Zhou ZY , et al. Kidney Failure Attributed to Focal Segmental Glomerulosclerosis: A USRDS Retrospective Cohort Study of Epidemiology, Treatment Modalities, and Economic Burden. Kidney Med 2024; 6: 100760.","DOI":"10.1016\/j.xkme.2023.100760"},{"key":"2025030100250630000_2025.02.26.25322958v1.4","unstructured":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work G. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 2021; 100: S1-S276."},{"key":"2025030100250630000_2025.02.26.25322958v1.5","doi-asserted-by":"crossref","unstructured":"Campbell KN , Pennese N , Zaffalon A , et al. Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis. Kidney Med 2022; 4: 100457.","DOI":"10.1016\/j.xkme.2022.100457"},{"key":"2025030100250630000_2025.02.26.25322958v1.6","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00425.2015"},{"key":"2025030100250630000_2025.02.26.25322958v1.7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/CS20240249","article-title":"Mechanism of protective actions of sparsentan in the kidney: lessons from studies in models of chronic kidney disease","volume":"138","year":"2024","journal-title":"Clin Sci (Lond"},{"key":"2025030100250630000_2025.02.26.25322958v1.8","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018010091"},{"key":"2025030100250630000_2025.02.26.25322958v1.9","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa2308550","article-title":"Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis","volume":"389","year":"2023","journal-title":"N Engl J Med"},{"key":"2025030100250630000_2025.02.26.25322958v1.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2010.01383.x"},{"key":"2025030100250630000_2025.02.26.25322958v1.11","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.90421.2008"},{"key":"2025030100250630000_2025.02.26.25322958v1.12","first-page":"39","article-title":"Cross-striated fibrils and other ultrastructural alterations in glomeruli of rats with daunomycin nephrosis","volume":"23","year":"1970","journal-title":"Lab Invest"},{"key":"2025030100250630000_2025.02.26.25322958v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.10.023"},{"key":"2025030100250630000_2025.02.26.25322958v1.14","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw443"},{"key":"2025030100250630000_2025.02.26.25322958v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.428"},{"key":"2025030100250630000_2025.02.26.25322958v1.16","doi-asserted-by":"crossref","unstructured":"Love MI , Huber W , Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014; 15: 550.","DOI":"10.1186\/s13059-014-0550-8"},{"key":"2025030100250630000_2025.02.26.25322958v1.17","doi-asserted-by":"crossref","unstructured":"Li Y , Andrade J . DEApp: an interactive web interface for differential expression analysis of next generation sequence data. Source Code Biol Med 2017; 12: 2.","DOI":"10.1186\/s13029-017-0063-4"},{"key":"2025030100250630000_2025.02.26.25322958v1.18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/30.1.207"},{"key":"2025030100250630000_2025.02.26.25322958v1.19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1193"},{"issue":"51","key":"2025030100250630000_2025.02.26.25322958v1.20","first-page":"D933","volume":"2023","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2025030100250630000_2025.02.26.25322958v1.21","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1021\/acs.jproteome.4c00411","article-title":"Crossing the Halfway Point: Aptamer-Based, Highly Multiplexed Assay for the Assessment of the Proteome","volume":"23","year":"2024","journal-title":"J Proteome Res"},{"issue":"Suppl 1","key":"2025030100250630000_2025.02.26.25322958v1.22","first-page":"S49","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29","year":"2008","journal-title":"Clin Biochem Rev"},{"key":"2025030100250630000_2025.02.26.25322958v1.23","doi-asserted-by":"crossref","unstructured":"Chen EY , Tan CM , Kou Y , et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 2013; 14: 128.","DOI":"10.1186\/1471-2105-14-128"},{"key":"2025030100250630000_2025.02.26.25322958v1.24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw377"},{"key":"2025030100250630000_2025.02.26.25322958v1.25","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90"},{"key":"2025030100250630000_2025.02.26.25322958v1.26","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-6783-4_11"},{"key":"2025030100250630000_2025.02.26.25322958v1.27","doi-asserted-by":"crossref","unstructured":"Fabregat A , Sidiropoulos K , Viteri G , et al. Reactome pathway analysis: a high- performance in-memory approach. BMC Bioinformatics 2017; 18: 142.","DOI":"10.1186\/s12859-017-1559-2"},{"key":"2025030100250630000_2025.02.26.25322958v1.28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz1031"},{"key":"2025030100250630000_2025.02.26.25322958v1.29","first-page":"F660","article-title":"Recruitment of renin gene-expressing cells in adult rat kidneys","volume":"259","year":"1990","journal-title":"Am J Physiol"},{"key":"2025030100250630000_2025.02.26.25322958v1.30","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.29.1.216"},{"key":"2025030100250630000_2025.02.26.25322958v1.31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.32.18719"},{"key":"2025030100250630000_2025.02.26.25322958v1.32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0031-6997(25)06838-3","article-title":"The pharmacologic alteration of renin release","volume":"32","year":"1980","journal-title":"Pharmacol Rev"},{"key":"2025030100250630000_2025.02.26.25322958v1.33","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btt703"},{"key":"2025030100250630000_2025.02.26.25322958v1.34","doi-asserted-by":"publisher","DOI":"10.1053\/J.AJKD.2021.10.004"},{"key":"2025030100250630000_2025.02.26.25322958v1.35","doi-asserted-by":"publisher","DOI":"10.1053\/J.AJKD.2016.03.416"},{"key":"2025030100250630000_2025.02.26.25322958v1.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2012.04.014"},{"key":"2025030100250630000_2025.02.26.25322958v1.37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.kint.2023.11.018","article-title":"Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"2025030100250630000_2025.02.26.25322958v1.38","doi-asserted-by":"crossref","unstructured":"Mishra A , Itoku A , Reidy K , et al. The Pursuit of New Treatments for Focal Segmental Glomerulosclerosis: Harmonizing Innovation With the DUET Study of Sparsentan. Kidney Med 2024; 6: 100844.","DOI":"10.1016\/j.xkme.2024.100844"},{"key":"2025030100250630000_2025.02.26.25322958v1.39","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.2147\/DMSO.S311725","article-title":"Complement C7 is Specifically Expressed in Mesangial Cells and is a Potential Diagnostic Biomarker for Diabetic Nephropathy and is Regulated by miR-494-3p and miR-574-5p","volume":"14","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2025030100250630000_2025.02.26.25322958v1.40","doi-asserted-by":"crossref","unstructured":"Helle F , Hultstrom M , Kavvadas P , et al. Deletion of Notch3 Impairs Contractility of Renal Resistance Vessels Due to Deficient Ca(2+) Entry. Int J Mol Sci 2022; 23.","DOI":"10.3390\/ijms232416068"},{"key":"2025030100250630000_2025.02.26.25322958v1.41","doi-asserted-by":"crossref","unstructured":"Thornton M , Sommer N , McGonigle M , et al. Notch3 deletion regulates HIV-1 gene expression and systemic inflammation to ameliorate chronic kidney disease. Dis Model Mech 2025; 18.","DOI":"10.1242\/dmm.052056"},{"key":"2025030100250630000_2025.02.26.25322958v1.42","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01360217"},{"key":"2025030100250630000_2025.02.26.25322958v1.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24998-6"},{"key":"2025030100250630000_2025.02.26.25322958v1.44","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-019-0715-7"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.02.26.25322958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:29:21Z","timestamp":1768508961000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2025.02.26.25322958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":44,"URL":"https:\/\/doi.org\/10.1101\/2025.02.26.25322958","relation":{},"subject":[],"published":{"date-parts":[[2025,2,27]]},"subtype":"preprint"}}